Dale Hooks compensation by year
Applied Therapeutics Summary Compensation Table · the one fiscal year held| Component | FY2024 |
|---|---|
| Salary | $375,852 |
| Bonus | $121,052 |
| Stock awards | $1,548,000 |
| Option awards | $0 |
| Non-equity incentive | $0 |
| Pension and deferred compensation | $0 |
| All other | $14,676 |
| Total | $2,059,580 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Applied Therapeutics, Inc. DEF 14A filed April 28, 2025, accession 0001193125-25-100674, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Applied Therapeutics, Inc. filed document, accession 0001193125-25-100674. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2025.
Equity holdings
unvested awards at FY2024 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 300,000 | $258,000 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in Applied Therapeutics, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.
Applied Therapeutics’s named executive officers, FY2024
as the company reported each| Named executive officer | Role | FY2024 total |
|---|---|---|
| Shoshana Shoshana | Shendelman, Ph.D. Former President, Chief Executive Officer and Secretary | $3,773,633 |
| John Johnson | Executive Chairman | $2,841,570 |
| Dale Hooks · this page | Chief Commercial Officer | $2,059,580 |
| Les Funtleyder | Interim Chief Executive Officer and Chief Financial Officer | $1,053,846 |
The full Applied Therapeutics compensation record
free company briefThis page is one person within Applied Therapeutics's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Applied Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.